D

Ceryvyn Therapeutics Limited CYVNY

OTC PK
Recommendation
Dividend Power Score
Day's Range
$0.02$0.02
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
Corporate Info
Phone Number
61 3 9826 0399
Address
117 Camberwell Road
Suite 1, Level 1
Hawthorn East, VIC 3123
Country
Australia
Year Founded
1984
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
--
Business Description
Ceryvyn Therapeutics Limited, a biopharmaceutical company, develops biologic therapy for the rare disease lymphangioleiomyomatosis in Australia. The company offers CYV-101, which is in pre-clinical trial stage, an inhaled therapy intended for delivery directly to the lung. It serves the biotechnology and healthcare industries. The company was formerly known as Opthea Limited and changed its name to Ceryvyn Therapeutics Limited in July 2026. Ceryvyn Therapeutics Limited was incorporated in 1984 and is headquartered in Hawthorn East, Australia.